Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective Study.

Naoaki OhkuboYusuke MiyazakiShingo NakayamadaShunsuke FukuyoYoshino InoueYurie Satoh-KandaHiroaki TanakaYasuyuki TodorokiHiroko MiyataAtsushi NagayasuMasashi FunadaHiroki KobayashiHidenori SakaiShumpei KosakaSatsuki MatsunagaYukiko TomoyoseHirotsugu NoharaYoshiya Tanaka

Published in: Rheumatology and therapy (2024)

IL-6Ri may potentially improve the disease activity of PMR compared to other bDMARDs.

Keyphrases

disease activity
giant cell
systemic lupus erythematosus
rheumatoid arthritis
rheumatoid arthritis patients
ankylosing spondylitis
juvenile idiopathic arthritis